News | Magnetic Resonance Imaging (MRI) | September 19, 2025

Cerebriu Secures CE-Mark for First OEM-Embedded AI Product with Siemens Healthineers

Cerebriu Secures CE Mark for First OEM-Embedded AI Product with Siemens Healthineers

Aug. 29, 2025 - Cerebriu recently announced it had received the CE mark for its Apollo Smart Protocol as an OEM-embedded solution within Siemens Healthineers MRI consoles.

The CE-mark represents a regulatory breakthrough — the first-ever clearance for embedded clinical AI in MRI systems from a leading global manufacturer. Combined with new funding, it paves the way for global deployment of intelligent MRI.

“Radiology is at a pivotal inflection point, where smart clinical AI will define scanner performance,” said Robert Lauritzen, CEO/co-founder of Cerebriu. “CE-marking of the OEM-embedded Apollo Smart Protocol validates the robustness of our technology and proves that AI can be seamlessly integrated into MRI systems at scale.”

Cerebriu’s Apollo Smart Protocol enables MRI technologists to adapt imaging protocols in real time, while the patient is still in the scanner. The AI makes it possible to tailor sequences based on detected pathologies, resulting in more personalized, efficient, and complete imaging in a single exam.

“We’re excited to work with Cerebriu to further unlock smarter MRI workflows. Their ability to integrate AI seamlessly into clinical practice has the potential to accelerate productivity and open new value for both providers and industry,” said Dr. Florian Meise, VP MR Portfolio, Partners and Digital at Siemens Healthineers.

With CE-marking secured for the OEM-integrated Apollo Smart Protocol and strategic partnerships underway with other MRI vendors, Cerebriu is now scaling its Apollo Suite across Europe, the U.S., Asia and the Middle East. The company is now working toward FDA clearance.


Related Content

News | Breast Imaging

Aug. 3, 2026 — GE HealthCare has launched Invenia ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue, a ...

Time August 03, 2026
arrow
News | Breast Imaging

July 30, 2026 — DeepHealth, Inc. has received FDA 510(k) clearance for DeepHealth Breast Ultrasound1, an AI-powered ...

Time July 31, 2026
arrow
News | Cardiac Imaging

July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...

Time July 15, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | Computed Tomography (CT)

June 10, 2026 — Subtle Medical has received FDA clearance for SubtleHD (CT), an AI-powered image enhancement solution ...

Time June 17, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
Subscribe Now